BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8771840)

  • 21. Ukrain: a novel antitumor drug.
    Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
    Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report).
    Steinacker J; Kroiss T; Korsh OB; Melnyk A
    Drugs Exp Clin Res; 1996; 22(3-5):275-7. PubMed ID: 8899347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of acute toxicity of Ukrain in rats after intravenous injection.
    Kulik GI; Deneka ER; Todor IN; Karmozina LG
    Drugs Exp Clin Res; 1998; 24(5-6):287-93. PubMed ID: 10190089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
    Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
    Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation.
    Boyko VN; Zholus RB
    Drugs Exp Clin Res; 1998; 24(5-6):331-3. PubMed ID: 10190098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Ukrain on the activities of DNA-nicking enzymes.
    Votrin II; Voltchek IV; Kurochkin SN; Kolobkov SL
    Drugs Exp Clin Res; 2000; 26(5-6):267-73. PubMed ID: 11345037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative: Ukrain.
    Liepins A; Nowicky JW
    Int J Immunopharmacol; 1992 Nov; 14(8):1437-42. PubMed ID: 1464476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma.
    Voltchek IV; Liepins A; Nowicky JW; Brzosko WJ
    Drugs Exp Clin Res; 1996; 22(3-5):283-6. PubMed ID: 8899349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 13,14-dihydrocoptisine--the genuine alkaloid from Chelidonium majus.
    Paulsen J; Yahyazadeh M; Hänsel S; Kleinwächter M; Ibrom K; Selmar D
    Phytochemistry; 2015 Mar; 111():149-53. PubMed ID: 25666130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure.
    Panzer A; Joubert AM; Eloff JN; Albrecht CF; Erasmus E; Seegers JC
    Cancer Lett; 2000 Nov; 160(2):237-41. PubMed ID: 11053654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of direct influence of Ukrain preparation on influenza viruses and the bacteria E. coli and S. aureus.
    Ciebiada I; Korczak E; Nowicky JW; Denys A
    Drugs Exp Clin Res; 1996; 22(3-5):219-23. PubMed ID: 8899335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic aspects of the relationship between isoquinoline alkaloids and mineral elements in greater celandine (Chelidonium majus L.)].
    Buzuk GN; Lovkova MIa; Sokolova SM; Tiutekin IuV
    Prikl Biokhim Mikrobiol; 2003; 39(1):37-42. PubMed ID: 12625040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chelidonium majus L. (Ukrain) in the treatment of cancer patients.
    Lohninger A; Hamler F
    Drugs Exp Clin Res; 1992; 18 Suppl():73-7. PubMed ID: 1305049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells.
    Gagliano N; Moscheni C; Torri C; Donetti E; Magnani I; Costa F; Nowicky W; Gioia M
    Anticancer Drugs; 2007 Jul; 18(6):669-76. PubMed ID: 17762395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theoretical grounds and experimental confirmation of the antiviral effect of the preparation Ukrain.
    Lozjuk RM; Lisnyak OI; Lozjuk LV
    Drugs Exp Clin Res; 1996; 22(3-5):213-7. PubMed ID: 8899334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ukrain(TM), a semisynthetic Chelidonium majus alkaloid derivative, acts by inhibition of tubulin polymerization in normal and malignant cell lines.
    Panzer A; Hamel E; Joubert AM; Bianchi PC; Seegers JC
    Cancer Lett; 2000 Nov; 160(2):149-57. PubMed ID: 11053644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro study of the effects of the new antitumor drug Ukrain and several cytostatic agents on the thiol groups in the tissue of Guerin carcinoma and its resistance to cisplatin variant.
    Kulik GI
    Drugs Exp Clin Res; 1998; 24(5-6):277-80. PubMed ID: 10190087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on the separation process of pharmacological active total alkaloids from Chelidonium majus L. growing in Georgia].
    Bozhadze AD; Vachnadze VIu; Dzhokhadze MS; Berashvili DT; Bakuridze AD
    Georgian Med News; 2013 Apr; (217):61-5. PubMed ID: 23676491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action of Ukrain, a cytostatic and immunomodulating drug, on effects of irradiation.
    Boyko VN; Voltchek IV; Petrov AS; Bubnov VP
    Drugs Exp Clin Res; 1996; 22(3-5):167-71. PubMed ID: 8899323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.